(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PRILOSEC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PRILOSEC

ST13

US500000074064327

Class

5

Filing

74064327

Registration

1665404

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

01/19/2022

Trademark type

Word

Nice classes

5

Filing date

05/31/1990

Registration date

11/19/1991

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/19/2022

Last transaction

01/19/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/01/1990

First use in commerce

10/01/1990

Drawing code

1

Owner type

03

Owner location

Södertälje, SE

Examiner

COFIELD, JULIA

Law office

G30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

ASTRAZENECA AB
A. A. (pessoa física)
A. A. (pessoa física)

Representatives

Cara M. Kearney AstraZeneca Pharmaceuticals LP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for the treatment of gastro intestinal diseases and disorders

Publications

History of USPTO decisions and trademark events.

37 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/19/2022

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

01/19/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/19/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/19/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

08/10/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/22/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/22/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/22/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/22/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/22/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/22/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/19/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/08/2019

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

12/27/2011

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/27/2011

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/27/2011

E89R

TEAS SECTION 8 & 9 RECEIVED

11/21/2011

CFIT

CASE FILE IN TICRS

11/30/2007

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/24/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/24/2007

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/20/2001

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/20/2001

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

10/09/2001

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/06/1997

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

01/13/1997

R.PR

REGISTERED-PRINCIPAL REGISTER

11/19/1991

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/25/1991

DOCK

ASSIGNED TO EXAMINER

09/04/1991

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/08/1991

EX1G

SOU EXTENSION 1 GRANTED

07/08/1991

IUAF

USE AMENDMENT FILED

05/30/1991

EXT1

SOU EXTENSION 1 FILED

05/30/1991

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

04/23/1991

PUBO

PUBLISHED FOR OPPOSITION

01/29/1991

NPUB

NOTICE OF PUBLICATION

12/28/1990

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/22/1990

DOCK

ASSIGNED TO EXAMINER

10/11/1990

Continuous trademark protection

Get notified about every new filing that threatens PRILOSEC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.